GU Cancers

Cancer Center Support Grant (CCSG) Programs

77 Grants

This is a chronological listing of grants held by this department, with the most recent listed first. New grants appear in this list quarterly and contribute to the department's Research Profile. The source of grants for this application comes directly from your institution.

• 1.

  Boyi Gan

  ELOVL6, a link between lipid metabolism and prostate cancer development?

  7/24/2012 - 7/23/2013

  Sponsor: US Department of Defense

• 2.

  Xifeng Wu

  Molecular pathways linking obesity and RCC tumorigenesis (PQ1)

  7/19/2012 - 7/31/2013

  Sponsor: National Cancer Institute - DHHS - NIH

• 3.

  Boyi Gan

  TSC-FoxO signaling network in kidney cancer development

  4/1/2012 - 7/31/2014

  Sponsor: US Department of Defense

• 4.

  Padmanee Sharma

  Targeting the ICOS/ICOSL pathway to improve anti-tumor immune responses

  2/29/2012 - 12/31/2016

  Sponsor: National Cancer Institute - DHHS - NIH

• 5.

  Yu Shen

  Technology Diffusion & Cost-Effectiveness of Mammography Screening in Older Women

  9/26/2011 - 8/31/2013

  Sponsor: National Cancer Institute - DHHS - NIH

• 6.

  Eric Jonasch

  Biannual von Hippel Lindau Family Alliance Medical Meeting

  9/16/2011 - 8/31/2012

  Sponsor: National Cancer Institute - DHHS - NIH

• 7.

  Renata Pasqualini

  High-throughput Screenings to Identify Host Receptors for Staphylococcal Adhesions

  1/1/2011 - 12/31/2012

  Sponsor: National Institute of Allergy and Infectious Diseases - DHHS - NIH

• 8.

  Xifeng Wu

  4th Meeting of the International Consortium of Bladder Cancer (ICBC)

  9/1/2010 - 8/31/2011

  Sponsor: National Cancer Institute - DHHS - NIH

• 9.

  Bogdan Czerniak

  Aurora Kinase A as a Biomarker for the Detection of Bladder Cancer

  7/6/2010 - 5/31/2014

  Sponsor: National Cancer Institute - DHHS - NIH

• 10.

  Wadih Arap

  Regulation of the paracrine angiogenic function of cardiac myocytes by cardiomyoc

  7/1/2010 - 5/31/2015

  Sponsor: National Heart, Lung, and Blood Institute - DHHS - NIH

• 11.

  Wadih Arap

  Novel Clinical Diagnostic Targets for Detection of Invasive Mold Aspergillosis

  6/1/2010 - 5/31/2012

  Sponsor: National Institute of Allergy and Infectious Diseases - DHHS - NIH

• 12.

  Renata Pasqualini

  ARRA-Combinatorial Targeting of Injury Sites with Peptide Libraries: Towards a Ligand-Directed Pharmacology in Wound Stasis

  6/1/2010 - 5/31/2012

  Sponsor: US Defense Advanced Research Projects Agency (DARPA)

• 13.

  Timothy Thompson

  Androgenic Regulation of White Adipose Tissue-Prostate Cancer Interactions

  5/1/2010 - 5/31/2013

  Sponsor: US Department of Defense

• 14.

  Bogdan Czerniak

  Genitourinary Tumor Samples (clear cell renal carcinoma and urothelial carcinomas of the bladder) for The Cancer Genome Atlas (TCGA) Project

  4/28/2010 - 9/30/2014

  Sponsor: National Cancer Institute - DHHS - NIH

• 15.

  Sue-Hwa Lin

  Cadherin-11 as a Target for Bone Metastasis Prevention

  3/1/2010 - 3/31/2013

  Sponsor: US Department of Defense

• 16.

  Padmanee Sharma

  ICOS-Expressing T Cells as Mediators of Antitumor Immune Responses

  2/1/2010 - 2/28/2013

  Sponsor: US Department of Defense

• 17.

  Christopher Logothetis

  MD Anderson Cancer Center Prostate SPORE

  9/2/2009 - 8/31/2014

  Sponsor: National Cancer Institute - DHHS - NIH

• 18.

  Christopher Logothetis

  MD Anderson Cancer Center Prostate Cancer Research Program Clinical Consortium Award

  9/1/2009 - 9/30/2014

  Sponsor: US Department of Defense

• 19.

  Renata Pasqualini

  Assessing Drug Response and Prognosis in Breast Cancer Using AAVP-Based Targeted Molecular-Genetic Imaging

  9/1/2009 - 8/31/2014

  Sponsor: US Department of Defense

• 20.

  Renata Pasqualini

  ARRA: Molecular Targeting of Lymphatic Endothelial Receptors for Ligand-directed Imaging

  8/3/2009 - 7/31/2011

  Sponsor: National Cancer Institute - DHHS - NIH

• 21.

  Padmanee Sharma

  CTLA-4 Blockade in Therapy of Prostate Cancer

  7/1/2009 - 6/30/2013

  Sponsor: American Cancer Society, National

• 22.

  Renata Pasqualini

  Targeted Modulation of Angiogenesis by VEGFR Peptidomimetic Antagonists

  6/1/2009 - 5/31/2013

  Sponsor: National Eye Institute - DHHS - NIH

• 23.

  Sue-Hwa Lin

  RSK2 in Prostate Cancer

  4/13/2009 - 5/12/2013

  Sponsor: US Department of Defense

• 24.

  Renata Pasqualini

  Vascular and Lymphatic Targeting

  1/20/2009 - 1/19/2010

  Sponsor: US Department of Defense

• 25.

  David McConkey

  Proteasome Inhibition and ER Stress

  1/1/2009 - 11/30/2013

  Sponsor: National Cancer Institute - DHHS - NIH

• 26.

  Randa El-Zein

  Cytokineses-blocked mircronucleus assay: a predictive biomarker of lung cancer risk.

  9/29/2008 - 8/31/2012

  Sponsor: National Cancer Institute - DHHS - NIH

• 27.

  Ivan Gorlov

  Tobacco Smoke Sensitive Genes and Genetic Susceptibility to Small-Cell Lung Cancer

  9/26/2008 - 8/31/2011

  Sponsor: National Cancer Institute - DHHS - NIH

• 28.

  Timothy Thompson

  Role of Caveolin-1 in Prostate Cancer Angiogenesis

  9/10/2008 - 12/14/2009

  Sponsor: US Department of Defense

• 29.

  Renata Pasqualini

  Integration of Vascular Genomics and Proteomics for Diagnosis and Therapy of Cancer

  9/8/2008 - 8/31/2011

  Sponsor: National Cancer Institute - DHHS - NIH

• 30.

  Jian Gu

  Telomere length, telomere maintenance gene polymorphisms, and bladder cancer risk

  7/1/2008 - 6/30/2013

  Sponsor: National Cancer Institute - DHHS - NIH

• 31.

  Jian Gu

  Telomere length, telomere maintenance gene polymorphisms, and bladder cancer risk

  7/1/2008 - 6/30/2013

  Sponsor: National Cancer Institute - DHHS - NIH

• 32.

  Nora Navone

  Beta-catenin/TCF Pathway and Castrate Resistant Progress

  5/12/2008 - 6/11/2012

  Sponsor: US Department of Defense

• 33.

  Xifeng Wu

  Genome-Wide Association Analysis of Bladder Cancer

  4/1/2008 - 3/31/2013

  Sponsor: National Cancer Institute - DHHS - NIH

• 34.

  Xifeng Wu

  Genetic Instability & Risk for Esophageal Carcinoma

  3/10/2008 - 1/31/2013

  Sponsor: National Cancer Institute - DHHS - NIH

• 35.

  Ivan Gorlov

  The Odd-Even Effect of Polymorphic CA Repeats in the 5 Regulatory Regionof the EGFR gene (rs1156315) on breast cancer risk

  9/24/2007 - 8/31/2010

  Sponsor: National Cancer Institute - DHHS - NIH

• 36.

  Xifeng Wu

  Application of the mutagen sensitivity DNA repair assay in the Spanish Bladder Cancer Study (SBCS)

  9/15/2007 - 8/31/2009

  Sponsor: National Cancer Institute - DHHS - NIH

• 37.

  Sara Strom

  Evaluating the Role of Genetic Markers in Prostate Cancer Progression: A Multi Ethnic Cohort Experience

  9/4/2007 - 10/3/2011

  Sponsor: US Department of Defense

• 38.

  Renata Pasqualini

  Vascular and Lymphatic Targeting for the Treatment of Traumatic Injuries - Development and Evaluation in a Swine Model

  7/31/2007 - 7/30/2010

  Sponsor: US Defense Advanced Research Projects Agency (DARPA)

• 39.

  Jian Gu

  Polymorphisms in Inflammation Genes and Bladder Cancer Risk

  7/1/2007 - 6/30/2010

  Sponsor: National Cancer Institute - DHHS - NIH

• 40.

  Renata Pasqualini

  Ligand-Directed Tumor Targeting in Preclinical Models

  6/1/2007 - 4/30/2012

  Sponsor: National Cancer Institute - DHHS - NIH

• 41.

  Fernanda Staquicini

  Breast Cancer-Derived Brain Metastases Therapy Using Neural Stem Cells

  9/1/2006 - 8/31/2007

  Sponsor: US Department of Defense

• 42.

  Sara Strom

  Molecular Epidemiology of t-MDS/AML

  4/1/2006 - 3/31/2009

  Sponsor: National Cancer Institute - DHHS - NIH

• 43.

  Christopher Logothetis

  Participating Center Application for Prostate Cancer Research Program Clinical Consortium Award

  1/3/2006 - 9/29/2009

  Sponsor: US Department of Defense

• 44.

  David McConkey

  Cell cycle dependence of TRAIL sensitivity in prostate cancer.

  10/24/2005 - 11/23/2009

  Sponsor: US Department of Defense

• 45.

  Renata Pasqualini

  Regulatory Roles for Vascular Peptidases in Angiogenesis

  8/1/2005 - 7/31/2009

  Sponsor: National Heart, Lung, and Blood Institute - DHHS - NIH

• 46.

  Sue-Hwa Lin

  Bone Metastasis Factor-1 in Prostate Cancer/Bone Interaction

  7/1/2005 - 4/30/2011

  Sponsor: National Cancer Institute - DHHS - NIH

• 47.

  Xifeng Wu

  Lung Cancer Chemoradiation: Predictors of Survival

  6/8/2005 - 4/30/2012

  Sponsor: National Cancer Institute - DHHS - NIH

• 48.

  Wadih Arap

  Molecular Diversity in Bladder Cancer

  6/1/2005 - 5/31/2010

  Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases - DHHS - N

• 49.

  Jian Gu

  Benzo[alpha]pyrene Diol Epoxide (BPDE) Sensitivity at 9p21 and Bladder Cancer Risk

  9/1/2004 - 8/31/2006

  Sponsor: National Cancer Institute - DHHS - NIH

• 50.

  Ashish Kamat

  Chemoprevention of murine urinary bladder carcinogenesis

  7/1/2004 - 6/30/2007

  Sponsor: National Cancer Institute - DHHS - NIH

• 51.

  Wadih Arap

  MAPPING VASCULAR DIVERSITY OF HUMAN CANCER

  3/15/2004 - 2/28/2007

  Sponsor: National Cancer Institute - DHHS - NIH

• 52.

  Curtis Pettaway

  Determining the Invasive Index in Prostate Biopsy and Radical Prostatectomy Specimens as Determined by the Matrix Metalloproteinase to E-cadherin Ratio.

  1/12/2004 - 2/11/2008

  Sponsor: US Department of Defense

• 53.

  David McConkey

  Regulation of calciuum fluxes and apoptosis by BCL-2 family proteins in prostate cancer cells.

  1/12/2004 - 2/11/2007

  Sponsor: US Department of Defense

• 54.

  Wadih Arap

  Imaging Tumor Blood Vessels in Bone Metastases from Breast Cancer

  9/10/2003 - 8/31/2008

  Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases - DHHS - N

• 55.

  Paul Corn

  Regulation of the von Hippel-Lindau Protein

  9/10/2003 - 8/31/2009

  Sponsor: National Cancer Institute - DHHS - NIH

• 56.

  Wadih Arap

  Stem Cell-Brain Tumor Interplay & In Vivo Phage Display

  8/15/2003 - 7/31/2007

  Sponsor: National Cancer Institute - DHHS - NIH

• 57.

  Randa El-Zein

  Molecular Biomarkers as Predictors of Hodgkins Disease

  8/1/2003 - 5/31/2010

  Sponsor: National Cancer Institute - DHHS - NIH

• 58.

  Xifeng Wu

  Genetic Susceptibility Modifiers in Renal Cell Carcinoma

  8/1/2003 - 5/31/2010

  Sponsor: National Cancer Institute - DHHS - NIH

• 59.

  Gary Gallick

  The Role of c-Src Activation in Prostate Tumor Progression

  7/1/2003 - 7/31/2006

  Sponsor: US Department of the Army

• 60.

  Nora Navone

  Cbfa1 and Prostate Cancer Bone Metastases

  5/1/2003 - 4/30/2008

  Sponsor: National Cancer Institute - DHHS - NIH

• 61.

  Jeri Kim

  Differential Gene Expression Induced by Antioxidants

  4/1/2003 - 3/31/2007

  Sponsor: National Cancer Institute - DHHS - NIH

• 62.

  William Benedict

  RB4 Intravesical Gene Therapy: Mechanisms of Cell Death

  4/1/2003 - 12/31/2008

  Sponsor: National Cancer Institute - DHHS - NIH

• 63.

  Wadih Arap

  Probing Surface Heterogenity of Metastatic Prostate Cancer Cells

  2/1/2002 - 2/25/2006

  Sponsor: US Department of the Army

• 64.

  Christopher Logothetis

  The Clinical Development of Thalidomide as an Angiogenesis Inhibitor Therapy for Prostate Cancer

  9/28/2001 - 10/31/2006

  Sponsor: US Department of the Army

• 65.

  Colin Dinney

  SPORE in Genitourinary Cancer

  9/25/2001 - 8/31/2012

  Sponsor: National Cancer Institute - DHHS - NIH

• 66.

  Christopher Logothetis

  The University of Texas M. D. Anderson SPORE in Prostate Cancer

  6/1/2001 - 12/31/2007

  Sponsor: National Cancer Institute - DHHS - NIH

• 67.

  Xifeng Wu

  Genetic Influence on Mutagen Sensitivity - A Twin Study

  5/4/2001 - 4/30/2006

  Sponsor: National Cancer Institute - DHHS - NIH

• 68.

  Ashish Kamat

  Training of Academic Urologic Oncologists

  8/1/2000 - 6/30/2011

  Sponsor: National Cancer Institute - DHHS - NIH

• 69.

  Sankar Maity

  Role of CBF/NF-Y in transcription: Type I collagen genes

  6/1/2000 - 5/31/2006

  Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases - DHH

• 70.

  Bogdan Czerniak

  Early Detection of Urinary Bladder Cancer

  9/30/1999 - 6/30/2010

  Sponsor: National Cancer Institute - DHHS - NIH

• 71.

  Sara Strom

  Prostate Cancer in Mexican Americans & African Americans

  9/30/1999 - 7/31/2006

  Sponsor: National Cancer Institute - DHHS - NIH

• 72.

  Yu Shen

  Statistical Methods for Breast Cancer Prevention and Treatment Studies

  8/1/1999 - 4/30/2015

  Sponsor: National Cancer Institute - DHHS - NIH

• 73.

  Menashe Bar Eli

  Malignant melanoma: Regulation by AP-2 and PAR1

  4/1/1999 - 5/31/2013

  Sponsor: National Cancer Institute - DHHS - NIH

• 74.

  Xifeng Wu

  Novel Markers of Genetic Susceptibility to Bladder Cancer

  2/22/1999 - 5/31/2011

  Sponsor: National Cancer Institute - DHHS - NIH

• 75.

  Timothy Thompson

  Mechanisms of Metastasis in Experimental Prostate Cancer

  8/1/1995 - 2/28/2012

  Sponsor: National Cancer Institute - DHHS - NIH

• 76.

  Bogdan Czerniak

  Paradigm of Multistep Urinary Bladder Carcinogenesis

  4/1/1995 - 11/30/2006

  Sponsor: National Cancer Institute - DHHS - NIH

• 77.

  Timothy Thompson

  Mechanisms of Progression in Oncogene-Induced Prostate Cancer

  9/8/1989 - 5/31/2012

  Sponsor: National Cancer Institute - DHHS - NIH